Condensed Consolidated Balance Sheets (Current Period Unaudited) - USD ($) $ in Thousands	Mar. 31, 2024	Dec. 31, 2023
Assets
Cash and cash equivalents	$ 128,231	$ 85,655
Investment securities available for sale, net of allowance for credit losses of $0	447,445	489,181
Loans, less allowance for credit losses of $13,157 at March 31, 2024 and $12,867 at December 31, 2023	966,141	948,604
Other real estate owned	357	357
Premises and equipment, net	12,960	18,948
Right-of-use assets	25,295	2,926
Bank owned life insurance	16,206	16,110
Goodwill	5,502	5,502
Accrued interest receivable and other assets	38,196	43,133
Total assets	1,640,333	1,610,416
Deposits:
Non-interest bearing	665,975	692,768
Interest bearing	633,713	640,887
Total deposits	1,299,688	1,333,655
Repurchase agreements	19,331	23,054
Lease liability	25,424	3,001
Accrued interest payable and other liabilities	14,399	13,389
Other borrowings	120,000	90,000
Total liabilities	1,478,842	1,463,099
Commitments and contingencies (Note 5)
Shareholders’ equity:
Common stock, no par value; 22,500,000 shares authorized; issued and outstanding – 5,895,595 shares at March 31, 2024 and 5,871,523 at December 31, 2023	28,492	28,033
Retained earnings	156,414	151,748
Accumulated other comprehensive loss, net	(23,415)	(32,464)
Total shareholders’ equity	161,491	147,317
Total liabilities and shareholders’ equity	$ 1,640,333	$ 1,610,416